Fig. 2From: Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumoursMMP-9 patterns. Above constructed patterns have been monitored for activities of MMP-9 in blood serum of individual subgroups of all hepatic carcinoma patents investigated in the current studyBack to article page